Results 251 to 260 of about 820,835 (359)

Characterisation and comparison of semen microbiota and bacterial load in men with infertility, recurrent miscarriage, or proven fertility. [PDF]

open access: yesElife
Mowla S   +18 more
europepmc   +2 more sources

Immunomodulatory effects of primed amniotic fluid-derived mesenchymal stem/stromal cells with IFN-γ from unexplained recurrent miscarriage sources. [PDF]

open access: yesSci Rep
Hoseini SM   +8 more
europepmc   +1 more source

Bridging the Ideological Divide: Advertising Strategies for Promoting Stigmatized Products

open access: yesPsychology &Marketing, EarlyView.
ABSTRACT Many socially relevant sexual and reproductive health products remain stigmatized by some consumers due to enduring socio‐cultural taboos, despite broader acceptance by others. Such stigma limits product adoption and poses public health risks.
Yunlu Zhao   +3 more
wiley   +1 more source

Efficacy of a K+ Channel Agonist, XEN1101, For Preserving Contractility in Mouse Models of Hypokalemic Periodic Paralysis

open access: yesMuscle &Nerve, EarlyView.
Pretreatment with an agonist of Kv7 potassium channels (XEN1101) protects the soleus muscle from a loss of force during a 2 mM K+ challenge, in a mouse model of hypokalemic periodic paralysis. ABSTRACT Introduction/Aims Effective management remains lacking for recurrent episodes of acute weakness in hypokalemic periodic paralysis (HypoPP).
Viktor Chanchykov   +4 more
wiley   +1 more source

Prototype and Chimera-Type Galectins in Placentas with Spontaneous and Recurrent Miscarriages [PDF]

open access: gold, 2016
Laura Unverdorben   +5 more
openalex   +1 more source

Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT

open access: yesObesity, EarlyView.
ABSTRACT Objective This post hoc analysis assessed psychiatric changes with tirzepatide in adults with obesity, without known major psychopathology, from SURMOUNT‐1, SURMOUNT‐2, and SURMOUNT‐3. Methods In participants (N = 4056) treated with tirzepatide (5/10/15 mg or maximum tolerated dose 10/15 mg) versus placebo, depressive symptoms and suicidal ...
Thomas A. Wadden   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy